Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript
Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.
Stay updated with breaking news from Exodx Prostate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.
MINNEAPOLIS, Oct. 31, 2023 /PRNewswire/ -- Bio-Techne Corporation today reported its financial results for the first quarter ended September 30, 2023. First Quarter FY2024 Highlights First quarter...
/PRNewswire/ -- The exosome diagnostics and therapeutics market size is set to grow by USD 483.18 million from 2022 to 2027 and register an accelerating CAGR...
Bio-Techne (NASDAQ:TECH – Get Rating) and Ocugen (NASDAQ:OCGN – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation. Risk & Volatility Bio-Techne has a beta of 1.26, meaning that its […]
Bio-Techne (NASDAQ:TECH – Get Rating) and Ocugen (NASDAQ:OCGN – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Risk & Volatility Bio-Techne has a beta of 1.25, suggesting that its […]